The role of oxidative stress in diabetic vascular and neural disease

被引:194
作者
Yorek, MA [1 ]
机构
[1] Univ Iowa, Vet Affairs Med Ctr 3E17, Iowa City, IA 52246 USA
[2] Univ Iowa, Dept Internal Med, Iowa City, IA 52246 USA
关键词
oxidative stress; diabetic vascular and neural disease; reactive oxygen species; superoxide dismutase;
D O I
10.1080/1071576031000083161
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review will focus on the impact of hyperglycemia-induced oxidative stress in the development of diabetes-induced vascular and neural dysfunction. Oxidative stress occurs when the balance between the production of oxidation products and the ability of antioxidant mechanisms to neutralize these products is tilted in the favor of the former. The production of reactive oxygen species has been shown to be increased in patients with diabetes. The possible sources for the overproduction of reactive oxygen species is widespread and include enzymatic pathways, autoxidation of glucose and the mitochondria. Increase in oxidative stress has clearly been shown to contribute to the pathology of vascular disease not only in diabetes but also in hypertension, stroke and ischemia. Since the etiology of diabetic neuropathy is considered to have a large vascular component, prevention of oxidative stress in diabetes is considered by many investigators to be a primary defense against the development of diabetic vascular disease. Potential therapies for preventing increased oxidative stress in diabetes and the neural vasculature will be discussed.
引用
收藏
页码:471 / 480
页数:10
相关论文
共 107 条
[1]   Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats [J].
Aggarwal, M ;
Singh, J ;
Sood, S ;
Arora, B .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (03) :131-134
[2]   Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[3]   Free radicals, diabetes and endothelial dysfunction [J].
Bayraktutan, U .
DIABETES OBESITY & METABOLISM, 2002, 4 (04) :224-238
[4]   Diabetic neuropathy [J].
Boulton, AJM ;
Malik, RA .
MEDICAL CLINICS OF NORTH AMERICA, 1998, 82 (04) :909-+
[5]   POTENTIAL USE OF GLUTATHIONE FOR THE PREVENTION AND TREATMENT OF DIABETIC NEUROPATHY IN THE STREPTOZOTOCIN-INDUCED DIABETIC RAT [J].
BRAVENBOER, B ;
KAPPELLE, AC ;
HAMERS, FPT ;
VANBUREN, T ;
ERKELENS, DW ;
GISPEN, WH .
DIABETOLOGIA, 1992, 35 (09) :813-817
[6]   Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats [J].
Brosnan, MJ ;
Hamilton, CA ;
Graham, D ;
Lygate, CA ;
Jardine, E ;
Dominiczak, AF .
JOURNAL OF HYPERTENSION, 2002, 20 (02) :281-286
[7]   NONENZYMATIC GLYCOSYLATION AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :527-537
[8]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[9]   Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? [J].
Bursell, SE ;
King, GL .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 45 (2-3) :169-182
[10]   ANGIOTENSIN CONVERTING ENZYME-INHIBITION PREVENTS DEVELOPMENT OF MUSCLE AND NERVE DYSFUNCTION AND STIMULATES ANGIOGENESIS IN STREPTOZOTOCIN-DIABETIC RATS [J].
CAMERON, NE ;
COTTER, MA ;
ROBERTSON, S .
DIABETOLOGIA, 1992, 35 (01) :12-18